Abstract
Cell lines from Nijmegen Breakage Syndrome (NBS) and ataxia telangiectasia (A-T) patients show defective S phase checkpoint arrest. In contrast, only A-T but not NBS cells are significantly defective in radiation-induced G1/S arrest. Phosphorylation of some ATM substrates has been shown to occur in NBS cells. It has, therefore, been concluded that Nbs1 checkpoint function is S phase specific. Here, we have compared NBS with A-T cell lines (AT-5762ins137) that express a low level of normal ATM protein to evaluate the impact of residual Nbs1 function in NBS cells. The radiation-induced cell cycle response of these NBS and ‘leaky’ A-T cells is almost identical; normal G2/M arrest after 2 Gy, intermediate G1/S arrest depending on the dose and an A-T-like S phase checkpoint defect. Thus, the checkpoint assays differ in their sensitivity to low ATM activity. Radiation-induced phosphorylation of the ATM-dependent substrates Chk2, RPAp34 and p53-Ser15 are similarly impaired in AT-5762ins137 and NBS cells in a dose dependent manner. In contrast, NBS cells show normal ability to activate ATM kinase following irradiation in vitro and in vivo. We propose that Nbs1 facilitates ATM-dependent phosphorylation of multiple downstream substrates, including those required for G1/S arrest.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abraham RT . 2001 Genes Dev. 15: 2177–2196
Antoccia A, Ricordy R, Maraschio P, Prudente S, Tanzarella C . 1997 Int. J. Radiat. Biol. 71: 41–49
Antoccia A, Stumm M, Saar K, Ricordy R, Maraschio P, Tanzarella C . 1999 Int. J. Radiat. Biol. 75: 583–591
Arlett CF, Green MHL, Priestley A, Harcourt SA, Mayne LV . 1988 Int. J. Radiat. Biol. 54: 911–926
Badie C, Goodhardt M, Waugh A, Doyen N, Foray N, Calsou P, Singleton B, Gell D, Salles B, Jeggo P, Arlett CF, Malaise E-P . 1997 Cancer Res. 57: 4600–4607
Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y . 1998 Science 281: 1674–1677
Beamish H, Lavin MF . 1994 Int. J. Radiat. Biol. 65: 175–184
Begg AC, Moonen L, Hofland I, Dessing M, Bartelink H . 1988 Radiother. Oncol. 11: 337–347
Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ . 2001 J. Biol. Chem. 276: 42462–42467
Buscemi G, Savio C, Zannini L, Micciche F, Masnada D, Nakanishi M, Tauchi H, Komatsu K, Mizutani S, Khanna K, Chen P, Concannon P, Chessa L, Delia D . 2001 Mol. Cell. Biol. 21: 5214–5222
Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD . 1998 Science 281: 1677–1679
Carney JP, Maser RS, Olivares H, Davis EM, Le Beau M, Yates IIIJR, Hays L, Morgan WF, Petrini JHJ . 1998 Cell 93: 477–486
Chen MJ, Lin YT, Lieberman HB, Chen G, Lee EY . 2001 J. Biol. Chem. 276: 16580–16586
Edwards RJ, Bentley NJ, Carr AM . 1999 Nature Cell Biology 1: 393–398
Featherstone C, Jackson SP . 1998 Current Biology 8: R622–R625
Gatei M, Young D, Cerosaletti KM, Desai-Mehta A, Spring K, Kozlov S, Lavin MF, Gatti RA, Concannon P, Khanna K . 2000 Nat. Genet. 25: 115–119
Girard P-M, Foray N, Stumm M, Waugh A, Riballo E, Maser RS, Phillips WP, Petrini J, Arlett CF, Jeggo PA . 2000 Cancer Res. 60: 4881–4888
Grenon M, Gilbert C, Lowndes NF . 2001 Nat. Cell Biol. 3: 844–847
Jaspers NGJ, Painter RB, Paterson MC, Kidson C, Inoue T . 1985 Ataxia-Telangiectasia: Genetics. Immunology and Neuropathology of a Degenerative Disease of Childhood Vol 19: Kroc Foundation Series Gatti RA and Swift MS (eds) Yew York: Alan R Liss pp 147–162
Jeggo PA, Carr AM, Lehmann AR . 1998 Trends Genet 14: 312–316
Jongmans W, Vuillaume M, Chrzanowska K, Smeets D, Sperling K, Hall J . 1997 Mol. Cell. Biol. 17: 5016–5022
Lakin ND, Weber P, Stankovic T, Rottinghaus ST, Taylor AMR, Jackson SP . 1996 Oncogene 13: 2707–2716
Lim DS, Kim ST, Xu B, Maser RS, Lin J, Petrini JH, Kastan MB . 2000 Nature 404: 613–617
Liu VF, Weaver DT . 1993 Mol. Cell. Biol. 13: 7222–7231
Maser RS, Zinkel R, Petrini JH . 2001 Nat. Genet. 27: 417–421
Matsuura K, Balmukhanov T, Tauchi H, Weemaes C, Smeets D, Chrzanowska K, Endou S, Matsuura S, Komatsu K . 1998 Biochem. Biophys. Res. Commun. 242: 602–607
McConville CM, Stankovic T, Byrd PJ, McGuire G, Yao Q-Y, Lennox GG, Taylor AMR . 1996 Am. J. Hum. Genet. 59: 320–330
Modesti M, Kanaar R . 2001 Curr. Biol. 11: R229–R232
Morgan SE, Kastan M . 1997 Cancer Res. 57: 3386–3389
Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM . 2000 Curr. Biol. 10: 886–895
Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor MR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y . 1995 Science 268: 1749–1753
Scott D, Spreadborough AR, Roberts SA . 1994 Int. J. Radiat. Biol. 66: S157–S163
Shiloh Y . 1997 Annu. Rev. Genet. 31: 635–662
Stankovic T, Kidd AMJ, Sutcliffe A, McGuire GM, Robinson P, Weber P, Bedenham T, Bradwell AR, Easton DF, Lennox GG, Haites N, Byrd PJ, Taylor AMR . 1998 Am. J. Hum. Genet. 62: 334–345
Stewart GS, Last JI, Stankovic T, Haites N, Kidd AM, Byrd PJ, Taylor AM . 2001 J. Biol. Chem. 276: 30133–30141
Stewart GS, Maser RS, Stankovic T, Bressan DA, Kaplan MI, Jaspers NG, Raams A, Byrd PJ, Petrini JH, Taylor AM . 1999 Cell 99: 577–587
Taalman RDFM, Hustinx TWJ, Weemaes CMR, Seemanova E, Schmidt A, Passarge E, Scheres JMJC . 1989 Am. J. Med. Genet. 32: 425–431
Taylor AMR, Harnden DG, Arlett CF, Harcourt SA, Lehmann AR, Stevens S, Bridges BA . 1975 Nature 258: 427–429
Taylor AMR, Hernandez D, McConville CM, Woods CG, Stacey M, Biggs P, Byrd CF, Arlett CF, Scott D . 1996a Genetic predisposition to cancer Eeles R, Ponder B, Easton D and Horwich EA (eds) London: Chapman and Hall pp 138–151
Taylor AMR, Metcalfe JA, Thick J, Mak YF . 1996b Blood 87: 423–438
Ward IM, Chen J . 2001 J. Biol. Chem. 276: 47759–47762
Wegner RD, Chrzanowska K, Sperling K, Stumm M . 1999 Primary immunodeficiency diseases, a molecular and genetic approach. Ochs HD, Puck JM and Smith CIE (eds) New York: Oxford University Press pp 324–334
Yamazaki V, Wegner RD, Kirchgessner CU . 1998 Cancer Res. 58: 2316–2322
Zhu J, Petersen S, Tessarollo L, Nussenzweig A . 2001 Curr. Biol. 11: 105–109
Acknowledgements
We thank Dr A Carr and AR Lehmann for help and support. Work contributing to this study was supported by grants from the Leukaemia Research Fund, the Industry-funded UKCCCR Radiation Research Programme, European Union grant FIGH CT 1999 00010 and an MRC ROPA award.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Girard, PM., Riballo, E., Begg, A. et al. Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest. Oncogene 21, 4191–4199 (2002). https://doi.org/10.1038/sj.onc.1205596
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205596
Keywords
This article is cited by
-
The cell cycle checkpoint inhibitors in the treatment of leukemias
Journal of Hematology & Oncology (2017)
-
Abnormalities in DNA double-strand break response beyond primary immunodeficiency
International Journal of Hematology (2011)
-
Meiotic localization of Mre11 and Rad50 in wild type, spo11-1, and MRN complex mutants of Coprinus cinereus
Chromosoma (2009)
-
Activation and regulation of ATM kinase activity in response to DNA double-strand breaks
Oncogene (2007)